T1	Outcomes 858 873	tumor shrinkage
T2	Outcomes 891 957	assessed by investigator (IR) and independent central review (ICR)
T3	Outcomes 1102 1122	mean tumor shrinkage
T4	Outcomes 1210 1233	Objective response rate
T5	Outcomes 1313 1334	disease control rates
T6	Outcomes 1483 1492	rash/acne
T7	Outcomes 1512 1520	diarrhea
T8	Outcomes 1544 1564	stomatitis/mucositis
T9	Outcomes 1742 1762	disease control rate
T10	Outcomes 1861 1879	antitumor activity
T11	Outcomes 2101 2117	clinical benefit